Home › Heart Attack › California › Los Angeles
Heart Attack clinical trials in Los Angeles, CA
4 studies for Heart Attack are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Academic Medical Research Institute, Los Angeles
- National Institute of Clinical Research, Inc., Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Keck Medical Center USC, Los Angeles
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- InvivoCure, Los Angeles
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RecruitingPhase 2
- Abcentra Investigational Site, Los Angeles
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- New York City, NY6 studies
- Dallas, TX6 studies
- Rochester, MN6 studies
- Boston, MA5 studies
- Detroit, MI4 studies
- Nashville, TN4 studies
- Hartford, CT4 studies
- Boca Raton, FL4 studies
- Knoxville, TN4 studies
- Houston, TX4 studies
- Greensboro, NC3 studies
- Austin, TX3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer71 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer49 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.